kringle-pharmaCo., Ltd.

NEWS

notice

Mar 02, 2020 Notice

Kringle Pharma successfully raises 950 million Japanese yen to advance clinical development of recombinant human HGF.

Kringle Pharma successfully raises 950 million Japanese yen to advance clinical development of recombinant human HGF.